INNERVATE RADIOPHARMACEUTICALS
Dead / Abandoned — Abandoned — no statement of use filed (as of 10 Nov 2025)
What this means for you
This application is over — abandoned 10 Nov 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97001206
- Mark type
- Stylized text
- Filed
- 30 Aug 2021
- Published for opposition
- 07 Feb 2023
- Abandoned
- 10 Nov 2025
- Attorney of record
- Daniel P. Mullarkey
Goods and services
- Class 005 — Pharmaceuticals: Anticancer pharmaceutical compounds; therapeutic and diagnostic radiopharmaceutical preparations; diagnostic radiopharmaceutical preparations for clinical, medical and research use in the cancer treatments, and cardiovascular treatments; radiopharmaceutical diagnostic preparations for medical use; diagnostic biomarker reagents for medical testing; diagnostic preparations and materials in the nature of diagnostic reagents and diagnostic media for bacteriological culture, for medical purposes; companion diagnostic agents, biomarkers, imaging agents, pet-imaging compounds, all for medical purposes
Owner
- INNERVATE RADIOPHARMACEUTICALS LLC, ENGLEWOOD, NJ, US
- INNERVATE RADIOPHARMACEUTICALS LLC, ENGLEWOOD, NJ, US
- Illumina Radiopharmaceuticals LLC, Englewood, NJ, US
Prosecution history
- 10 Nov 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 10 Nov 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 12 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2025 — SOU EXTENSION 4 GRANTED
- 11 Mar 2025 — SOU EXTENSION 4 FILED
- 11 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Aug 2024 — SOU EXTENSION 3 GRANTED
- 06 Aug 2024 — SOU EXTENSION 3 FILED
- 06 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 17 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Feb 2024 — SOU EXTENSION 2 GRANTED
- 16 Feb 2024 — SOU EXTENSION 2 FILED
- 16 Feb 2024 — SOU TEAS EXTENSION RECEIVED
- 20 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED